Acute Myeloid Leukemia, With NPM1 Mutations

Oncology·MeSH: Leukemia, Myeloid, Acute

Prevalence

30.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Acute Myeloid Leukemia, With NPM1 Mutations?

There are 1 clinical trial targeting Acute Myeloid Leukemia, With NPM1 Mutations tracked by BioSniper.

What is the prevalence of Acute Myeloid Leukemia, With NPM1 Mutations?

The estimated prevalence of Acute Myeloid Leukemia, With NPM1 Mutations is approximately 30.0 per 100,000 population.

Deep-dive into Acute Myeloid Leukemia, With NPM1 Mutations

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Acute Myeloid Leukemia, With NPM1 Mutations — Drugs in Development & Clinical Trials | BioSniper